It was found that down-regulation of FBXO43 could inhibit the proliferation, migration and invasion of HCC cells, revealing the pro-tumor effect of FBXO43, consistent with its role in breast cancer (Ma et al., 2021). Here, FBXO43 is linked to breast carcinoma.